Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation.

B Matoskova; W T Wong; A E Salcini; P G Pelicci; P P Di Fiore

Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation.

B Matoskova, W T Wong, A E Salcini, P G Pelicci, P P Di Fiore

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

68 Citationer (Scopus)

Abstract

Udgivelsesdato: 1995-Jul

Originalsprog	Engelsk
Tidsskrift	Molecular and Cellular Biology
Vol/bind	15
Udgave nummer	7
Sider (fra-til)	3805-12
Antal sider	7
ISSN	0270-7306
Status	Udgivet - 1995

Bibliografisk note

Keywords: Adaptor Proteins, Signal Transducing; Animals; Cell Transformation, Neoplastic; Cytoskeletal Proteins; Epidermal Growth Factor; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mitogens; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Proteins; Receptor, Epidermal Growth Factor; Recombinant Proteins; Signal Transduction; Tumor Cells, Cultured

Citationsformater

@article{688cdbc0519d11dd8d9f000ea68e967b,

title = "Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation.",

abstract = "eps8, a recently identified tyrosine kinase substrate, has been shown to augment epidermal growth factor (EGF) responsiveness, implicating it in EGF receptor (EGFR)-mediated mitogenic signaling. We investigated the status of eps8 phosphorylation in normal and transformed cells and the role of eps8 in transformation. In NIH 3T3 cells overexpressing EGFR (NIH-EGFR), eps8 becomes rapidly phosphorylated upon EGF stimulation. At receptor-saturating doses of EGF, approximately 30% of the eps8 pool is tyrosine phosphorylated. Under physiological conditions of activation (i.e., at low receptor occupancy), corresponding to the 50% effective dose of EGF for mitogenesis, approximately 3 to 4% of the eps8 contains phosphotyrosine. In human tumor cell lines, we detected constitutive tyrosine phosphorylation of eps8, with a stoichiometry (approximately 5%) similar to that associated with potent mitogenic response in NIH-EGFR cells. Overexpression of eps8 was able to transform NIH 3T3 cells under limiting conditions of activation of the EGFR pathway. Concomitant tyrosine phosphorylation of eps8 and shc, but not of rasGAP, phospholipase C-gamma, and eps15, was frequently detected in tumor cells. This suggested that eps8 and shc might be part of a pathway which is preferentially selected in some tumors. Cooperation between these two transducers was further indicated by the finding of their in vivo association. This association was, at least in part, dependent on recognition of shc by the SH3 domain of eps8. Our results indicate that eps8 is physiologically part of the EGFR-activated signaling and that its alterations can contribute to the malignant phenotype.",

author = "B Matoskova and Wong, {W T} and Salcini, {A E} and Pelicci, {P G} and {Di Fiore}, {P P}",

note = "Keywords: Adaptor Proteins, Signal Transducing; Animals; Cell Transformation, Neoplastic; Cytoskeletal Proteins; Epidermal Growth Factor; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mitogens; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Proteins; Receptor, Epidermal Growth Factor; Recombinant Proteins; Signal Transduction; Tumor Cells, Cultured",

year = "1995",

language = "English",

volume = "15",

pages = "3805--12",

journal = "Molecular and Cellular Biology",

issn = "0270-7306",

publisher = "American Society for Microbiology",

number = "7",

}

TY - JOUR

T1 - Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation.

AU - Matoskova, B

AU - Wong, W T

AU - Salcini, A E

AU - Pelicci, P G

AU - Di Fiore, P P

N1 - Keywords: Adaptor Proteins, Signal Transducing; Animals; Cell Transformation, Neoplastic; Cytoskeletal Proteins; Epidermal Growth Factor; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mitogens; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Proteins; Receptor, Epidermal Growth Factor; Recombinant Proteins; Signal Transduction; Tumor Cells, Cultured

PY - 1995

Y1 - 1995

N2 - eps8, a recently identified tyrosine kinase substrate, has been shown to augment epidermal growth factor (EGF) responsiveness, implicating it in EGF receptor (EGFR)-mediated mitogenic signaling. We investigated the status of eps8 phosphorylation in normal and transformed cells and the role of eps8 in transformation. In NIH 3T3 cells overexpressing EGFR (NIH-EGFR), eps8 becomes rapidly phosphorylated upon EGF stimulation. At receptor-saturating doses of EGF, approximately 30% of the eps8 pool is tyrosine phosphorylated. Under physiological conditions of activation (i.e., at low receptor occupancy), corresponding to the 50% effective dose of EGF for mitogenesis, approximately 3 to 4% of the eps8 contains phosphotyrosine. In human tumor cell lines, we detected constitutive tyrosine phosphorylation of eps8, with a stoichiometry (approximately 5%) similar to that associated with potent mitogenic response in NIH-EGFR cells. Overexpression of eps8 was able to transform NIH 3T3 cells under limiting conditions of activation of the EGFR pathway. Concomitant tyrosine phosphorylation of eps8 and shc, but not of rasGAP, phospholipase C-gamma, and eps15, was frequently detected in tumor cells. This suggested that eps8 and shc might be part of a pathway which is preferentially selected in some tumors. Cooperation between these two transducers was further indicated by the finding of their in vivo association. This association was, at least in part, dependent on recognition of shc by the SH3 domain of eps8. Our results indicate that eps8 is physiologically part of the EGFR-activated signaling and that its alterations can contribute to the malignant phenotype.

AB - eps8, a recently identified tyrosine kinase substrate, has been shown to augment epidermal growth factor (EGF) responsiveness, implicating it in EGF receptor (EGFR)-mediated mitogenic signaling. We investigated the status of eps8 phosphorylation in normal and transformed cells and the role of eps8 in transformation. In NIH 3T3 cells overexpressing EGFR (NIH-EGFR), eps8 becomes rapidly phosphorylated upon EGF stimulation. At receptor-saturating doses of EGF, approximately 30% of the eps8 pool is tyrosine phosphorylated. Under physiological conditions of activation (i.e., at low receptor occupancy), corresponding to the 50% effective dose of EGF for mitogenesis, approximately 3 to 4% of the eps8 contains phosphotyrosine. In human tumor cell lines, we detected constitutive tyrosine phosphorylation of eps8, with a stoichiometry (approximately 5%) similar to that associated with potent mitogenic response in NIH-EGFR cells. Overexpression of eps8 was able to transform NIH 3T3 cells under limiting conditions of activation of the EGFR pathway. Concomitant tyrosine phosphorylation of eps8 and shc, but not of rasGAP, phospholipase C-gamma, and eps15, was frequently detected in tumor cells. This suggested that eps8 and shc might be part of a pathway which is preferentially selected in some tumors. Cooperation between these two transducers was further indicated by the finding of their in vivo association. This association was, at least in part, dependent on recognition of shc by the SH3 domain of eps8. Our results indicate that eps8 is physiologically part of the EGFR-activated signaling and that its alterations can contribute to the malignant phenotype.

M3 - Journal article

C2 - 7791787

SN - 0270-7306

VL - 15

SP - 3805

EP - 3812

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

IS - 7

ER -